Ministry of Agriculture technical, cooperative officers undergo drone trainingHorizon Aircraft Secures $8.4 Million Strategic InvestmentNoneNetizens Name Dating Show Star As Yoo Byung Jae’s Rumored Girlfriend
Canadian Imperial Bank of Commerce stock falls Tuesday, underperforms market
Sean Penn blames Hollywood’s “extraordinary cowardice” for “limiting” filmS Korea expresses regret to Japan over memorial for mine workersOn November 23, Mnet held the third and final day of the 2024 MAMA Awards at the Kyocera Dome in Osaka, Japan. This was the concluding night of the award ceremony, bringing some big wins for the world’s top K-Pop artists . Aespa was among the groups that took home more than one award. Aespa’s “Supernova” won “Song of the Year,” “Best Choreography,” and “Best Dance Performance Female Group,” while “Armageddon” earned them the award for “Best Music Video.” [ #2024MAMA ] BEST MUSIC VIDEO #aespa #에스파 @aespa_official #Armageddon We proudly announce the great winner of the 2024 MAMA AWARDS!🏆 BIG BLUR : What is Real? 2024 MAMA AWARDS #MAMAAWARDS #2024MAMAAWARDS pic.twitter.com/07wGtAPBKB — MAMA AWARDS (@MnetMAMA) November 23, 2024 aespa is sweeping MAMA 2024 😮💨😭 🏆 “Best Female Group” 🏆 “Best Choreography” 🏆 “Best Dance Performance Female Group” 🏆 “Fan’s Choice Award — TOP 10” 🔜 “Best MV” 🔜 “Song of the Year” 🔜 “Album of the Year” 🔜 “Artist of the Year” — echi (@aechi___) November 23, 2024 Best Music Video – ARMAGEDDON (aespa) 💯 pic.twitter.com/jDBhCkILYc — Jazz (@mjkmwntr) November 23, 2024 Naturally, aespa’s fans were excited for the group. Many felt their wins were well-deserved, especially for the music video. Yet, netizens argued that other artists’ music videos were more deserving. i love aespa but love wins all mv was an absolute masterpiece pls 😭😭😭😭😭 https://t.co/HY4QcGDpWN — ᴗ̈ lee (@okeydokeykyeom) November 24, 2024 I love aespa but lets be real the best MV's this year are Girls Never Die and HEYA a close second #2024MAMA pic.twitter.com/UGjU8bVQkM — Supreet S (@BacardixCola) November 23, 2024 And if I say Seventeen was robbed of Best Music video for Maestro- An MV which used AI in it won over an MV that didn't and conveyed the message that AI is harmful and can never replace human art https://t.co/WL2NOciVGj pic.twitter.com/3OTlJS6mnM — ASH (@honouredbysvt) November 24, 2024 One common criticism of aespa’s “Armageddon” MV is that it utilized AI (Artificial Intelligence). AI usage is a common debate, as many are opposed to the usage of AI, and there’s a discourse on its ethicality. Many feel that AI is stealing jobs; in this case, specifically, they thought it insulted hardworking artists. Ya show is actually rigged cuz why tf they gave aespa best choreography with that boring ass dance and also best mv where ai is used. With more 2 awards that they were not even predicted to win https://t.co/m6yDW3RWBv — Zoe☆17 (@yoon1004hannie) November 24, 2024 Fans jumped to aespa’s defense, as the AI clip in the MV is used for 2 seconds. Most of the MV was created by real artists using 3D modeling/rendering and VFX. generative ai???? Dont discredit aespa’s hardwork especially their teams of editors, creative directors and everyone who was part of this masterpiece. Something not commonly seen “normal”, doesnt mean its all ai. https://t.co/ccWYeAROhY — xo, trisH 🐹 (@lhs_h7) November 25, 2024 You got idols that use HEAVY ai for teasers and photos and actual music videos, but y’all just want to talk about aespa’s under-2-seconds-of-ai for wtv reason. And ik it’s not just cause it won best mv. People BEEN on them for this. People just want a reason to hate aespa lmaoooo https://t.co/CjIg72BWBi — savae ❤️🤎 WHIPLASH (@aespaholo) November 25, 2024 Its called 3D modeling/rendering and VFX, not that Carats know something like that bec these days yall call everything made by AI when there are real artists pouring their heart and time into every detail of aespa's MV pic.twitter.com/OtQN5hC9LE — ACEWNTR |❄️윈터 (@draecaryssss) November 24, 2024 Besides, this is not the case when randomly using AI to be “trendy.” Aespa’s lore has long been intertwined with the Metaverse, with each member having their own computer-generated æ-aespa counterparts. There’s also the additional “member” of Nævis (also known as NAVIS or Naevis), another AI in aespa’s universe responsible for helping the group and their avatars coexist as they fight the fictional Black Mamba villain. So, it’s on brand for aespa as a group to include AI. Just because you don't do research and educate yourselves about art and vfx doesn't mean everything is done by AI, credits to all the people that worked on this MV — even adding a special thanks to MY since our fandom appreciate aespa's artistry (aespacore) pic.twitter.com/jiGcXWoZPm — ACEWNTR |❄️윈터 (@draecaryssss) November 25, 2024 not to mention aespa uses ai to enhance their futuristic/surreal concept, just like the ai lipsync in supernova, its not just there cus the artists were lazy https://t.co/lKsUxBqk2i — ren (@renomenonn) November 25, 2024 when are yall going to acknowledge the fact that ai is literally part of aespa's concept?? it's about the progress of the technology and futurism. the generated part of the mv was only like 2 seconds anyway yet they still wanted to include it and that's it. suck it up already. https://t.co/qTpDapObkZ — zuzu (@PRAWILNYCHEN) November 25, 2024 Some of the original critical tweets have since been deleted. Still, some K-Pop fans are standing their ground regarding not using AI. I'm really sorry, but ai is ai nonetheless no matter how many seconds it counts. It shows that it's getting commercialized and generalized in the creative industry. I'm happy Aespa got their bag but that doesn't mean its condoning SM from using ai for their artists' mvs https://t.co/nQQFm7GpFR — Rei or Rhey, call me whatever (@mochi_mangga) November 25, 2024 What do you think about the AI usage? aespa Korean Announcer Claims To Look Like aespa’s Karina Unexpected Story Of Popular Korean Star Meeting aespa’s Karina For The First Time Is Going Viral Rookie Girl Group Gets Accused Of Copying aespa Aespa’s Giselle Goes Viral For Her Visuals Despite Having An Allergic Reaction See more aespa
Malik Nabers: ‘I still stand on what I said’ after meeting with Joe Schoen, Brian Daboll to discuss postgame criticismNone
Mwalola wa Mwalola, a longtime fisherman in the Indian Ocean on the Kenyan coast, vividly remembers the events of the deadly tsunami of 20 years ago. Mwalola said the fisherfolk's experience and knowledge of the ocean saved his life after they sensed danger and decided to keep off the ocean on the fateful day. “My place of work was hit, but I was not affected because I heeded the warning," he said. "We avoided losses because we warned our colleagues of the impending danger and asked everyone to keep off the ocean that day.” On December 26, 2004, a powerful earthquake off the coast of the Indonesian island of Sumatra generated a devastating tsunami that was observed worldwide and caused tremendous devastation and deaths throughout the Indian Ocean region, including in East Africa. Out of the 228,000 people killed, more than 300 were from the East African countries of Somalia, Tanzania and Kenya, according to the U.N. Educational, Scientific and Cultural Organization. The disaster raised awareness about the threat tsunamis pose to coastal communities around the world and the need for improved tsunami detection, forecasting, warning and preparedness. Observers say more remains to be done in the East African countries that were affected. Shamim Wasii Nyanda, an environmental activist at the Tanzania Ocean Climate Innovation Hub in Dar es Salaam, said, "There’s an increase of vulnerability due to climate change but also ... limited adaptation funding. Most of the coastal cities lack sufficient financial resources to implement these climate adaptation measures, particularly in urban, under-resourced communities. They do not have that kind of technology or resources for them to be able to work on these problems that we are experiencing," especially tsunamis. Nyanda said increasing urbanization is compounding the risk. “Coastal cities like Dar es Salaam itself have continued to expand, with informal settlements encroaching on vulnerable areas where facilities like disasterproof housing and infrastructure are not available." People then build housing in areas where they shouldn't, "so, when these disasters come, like the tsunami, they are not prepared. They do not have the technology. They do not have the infrastructure ... and what happens? They are just swept away.” As countries observe the 20th anniversary of the 2004 tsunami, experts say preparedness, prevention and mitigation measures are key in preventing such disasters in the future.
Netflix Inc. stock underperforms Tuesday when compared to competitors despite daily gains
Published 4:58 pm Tuesday, November 26, 2024 By Data Skrive Top 25 teams will take the court in six games on Wednesday’s college basketball slate. That includes the Ole Miss Rebels squaring off against the UConn Huskies at Baha Mar Convention Center. Watch women’s college basketball, other live sports and more on Fubo. What is Fubo? Fubo is a streaming service that gives you access to your favorite live sports and shows on demand. Use our link to sign up for a free trial. Get the latest news sent to your inbox Catch tons of live women’s college basketball , plus original programming, with ESPN+ or the Disney Bundle.Enrollment and implant procedures completed in NIH funded feasibility study of LGS, a severe and disabling childhood-onset epilepsy MOUNTAIN VIEW, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced completion of enrollment and implant procedures in its feasibility investigational device exemption (IDE) study of the RNS® System for the treatment of Lennox-Gastaut Syndrome (LGS), a devastating form of childhood-onset epilepsy characterized by cognitive dysfunction and frequent generalized onset seizures that often lead to injury. The IDE study uses the RNS System, which has demonstrated safety and effectiveness of brain-responsive stimulation for treating medically intractable focal onset seizures in people 18 and older, to evaluate whether brain-responsive neurostimulation can also be used to treat LGS. NeuroPace received a $9.3 million National Institutes of Health (NIH) grant through the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative to evaluate its responsive neuromodulation technology in those who suffer from LGS. The IDE study funded by the grant was conducted at six sites and enrolled a total of 20 patients 12 years of age and older with LGS and drug-resistant generalized onset seizures. The study will evaluate the safety and effectiveness of the RNS System in treating seizures associated with LGS. "We are pleased to announce the advancement of our LGS IDE study and look forward to the data and learnings it provides. The results from this study could support further research of RNS therapy to improve the treatment of people with LGS. We appreciate the dedicated efforts of the investigators, research teams, participants and their families,” said Martha Morrell, MD, Chief Medical Officer of NeuroPace. "After completing the one-year open label period, participants will transition to the long-term follow-up period, which will continue over the next 18 months.” "LGS is a devastating, childhood-onset seizure disorder that leads to lifelong disability. 85% of those with LGS continue to have seizures into adulthood despite aggressive treatment, 98% suffer from intellectual disability, and they are 12 times more likely to die prematurely than others their age," said Tracy Dixon-Salazar, PhD, Executive Director of the LGS Foundation and mother of an adult living with LGS. "LGS families desperately need innovative treatment options to manage their seizures, and we are excited about this new study." Disclaimer: Research reported in this press release was supported by the National Institutes of Health's Brain Research Through Advancing Innovative Neurotechnologies (BRAIN) Initiative under award number UH3NS109557. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. About the RNS® System The RNS® System, a paradigm-shifting treatment for drug-resistant focal epilepsy, is the only brain-responsive neuromodulation system approved by the FDA. The closed-loop technology delivers personalized, data-driven treatment targeted to the seizure source by continuously monitoring brain activity, recognizing a patient's unique seizure pattern, and responding in real-time with imperceptible stimulation to prevent seizures. By recording ongoing EEG data, the RNS System provides physicians with a unique "window to the brain,” enabling them to remotely monitor their patients, gain insights based on brain activity, and use that information to optimize patient care. Long-term clinical studies demonstrate that the RNS System provides significant reduction in seizure frequency and enduring improvements in quality of life and cognition with no stimulation-related side effects. The RNS System is available at most comprehensive epilepsy centers in the United States and is widely covered by insurance. It is currently approved in the United States as an adjunctive therapy for patients 18 years of age and older with drug-resistant focal epilepsy. See full indication for use and important safety information at www.neuropace.com/safety/ . About NeuroPace, Inc. Based in Mountain View, Calif., NeuroPace is a commercial-stage medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients suffering from drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. Forward Looking Statements This press release may contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as "aims,” "anticipates,” "believes,” "could,” "estimates,” "expects,” "forecasts,” "goal,” "intends,” "may,” "plans,” "possible,” "potential,” "seeks,” "will” and variations of these words or similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements as a result of various factors, including: risks related to regulatory compliance and expectations for regulatory approvals to expand the market for NeuroPace's RNS System and other important factors. These and other risks and uncertainties include those described more fully in the section titled "Risk Factors” and "Management's Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in NeuroPace's public filings with the U.S. Securities and Exchange Commission (SEC), including its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the SEC on November 12 , 2024, as well as any other reports that it may file with the SEC in the future. Forward-looking statements contained in this announcement are based on information available to NeuroPace as of the date hereof. NeuroPace undertakes no obligation to update such information except as required under applicable law. These forward-looking statements should not be relied upon as representing NeuroPace's views as of any date subsequent to the date of this press release and should not be relied upon as a prediction of future events. In light of the foregoing, investors are urged not to rely on any forward-looking statement in reaching any conclusion or making any investment decision about any securities of NeuroPace. Investor Contact: Jeremy Feffer Managing Director LifeSci Advisors [email protected]None
Exelixis stock hits 52-week high at $36.6 amid robust growth
Singh won't support Conservative non-confidence motion that uses his own words
OpenAI’s Sora Tool Leaked By Group Of Aggrieved Early Testers